Insightmg

Source: JAMA Abstract: Importance: Fremanezumab, a fully humanized monoclonal antibody that targets calcitonin gene-related peptide, may be effective for treating episodic migraine. Conclusions and Relevance: Among patients with episodic migraine in whom multiple medication classes [...]

Source: Institute for Clinical and Economic Review (ICER) A recently released Institute for Clinical and Economic Review (ICER) evidence report assessing the comparative clinical effectiveness and value of three calcitonin gene-related peptide (CGRP) inhibitors for [...]

Source: American Academy of Neurology (AAN) While it has been known that estrogen plays a role in migraine for women, new research shows that the female sex hormone may also play a role in migraine [...]

Source: American Headache Society At the American Headache Society (AHS)'s 60th Annual Scientific Meeting, leading migraine experts are presenting five clinical studies that deepen the understanding of the effects of episodic and chronic migraine on [...]

Source: Institute for Clinical and Economic Review The Institute for Clinical and Economic Review released a final evidence report on three calcitonin gene-related peptide (CGRP) inhibitors for prevention of migraine. Panel members voted that evidence [...]

Source: Newcastle University, U.K. Experts at Newcastle University say introducing an electronic referral system to speed up diagnosis and treatment is likely to improve quality of life and save money.Full story...

Source: Frontiers in Molecular Biosciences The study, in Frontiers in Molecular Biosciences, suggests that sex hormones affect cells around the trigeminal nerve and connected blood vessels in the head, with estrogens -- at their highest [...]

Source: PubMed.govRead the abstract.